Detailed Information on Publication Record
2019
Adipokine gene variability and plasma levels in patients with chronic periodontitis - a case-control study
BOŘILOVÁ LINHARTOVÁ, Petra, Július JÁNOŠ, Hana POSKEROVÁ, Denisa KAVŘÍKOVÁ, Antonín FASSMANN et. al.Basic information
Original name
Adipokine gene variability and plasma levels in patients with chronic periodontitis - a case-control study
Authors
BOŘILOVÁ LINHARTOVÁ, Petra (203 Czech Republic, belonging to the institution), Július JÁNOŠ (703 Slovakia, belonging to the institution), Hana POSKEROVÁ (203 Czech Republic, belonging to the institution), Denisa KAVŘÍKOVÁ (203 Czech Republic, belonging to the institution), Antonín FASSMANN (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution) and Lydie IZAKOVIČOVÁ HOLLÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
BRAZILIAN ORAL RESEARCH, SAO PAULO, SOCIEDADE BRASILEIRA DE PESQUISA ODONTOLOGICA, 2019, 1807-3107
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30208 Dentistry, oral surgery and medicine
Country of publisher
Brazil
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.633
RIV identification code
RIV/00216224:14110/19:00107509
Organization unit
Faculty of Medicine
UT WoS
000468342300001
Keywords in English
Chronic Periodontitis; Diabetes Mellitus; Type 2; Adipokines
Tags
International impact, Reviewed
Změněno: 29/4/2020 07:46, Mgr. Tereza Miškechová
Abstract
V originále
Specific variants in genes that encode adipokines and their mRNA and protein expression were previously studied in type 2 diabetes mellitus (T2DM) and obesity, and similar studies have been performed for chronic periodontitis (CP). The aim of this case-control study was to investigate the possible impacts of adiponectin (ADIPOQ), leptin (LEP) and its receptor (LEPR), and resistin (RETN) on the etiopathogenesis of CP. Examinations were performed on 118 non-periodontitis healthy subjects (healthy controls, HC), 205 healthy individuals with CP (H + CP) and 86 type 2 diabetes patients with CP (T2DM + CP). Variants within the ADIPOQ (rs2241766, rs1501299), LEP (rs13228377, rs2167270), LEP receptor (rs1805096), and RETN (rs1862513) genes were determined by qPCR. In addition, the plasma levels of ADIPOQ, LEP, and RETN were analysed by ELISA for 80 individuals. The genotype frequencies of the SNP ADIPOQ + 45G/T (rs2241766) differed between the HC and H + CP groups (p=0.03, p(corr)>0.05), and carriers of the TT genotype had a lower risk of developing CP compared to carriers of the GG or TG genotypes (p<0.01, p(corr)>0.05). However, there were no significant differences in the plasma levels of ADIPOQ, LEP or RETN between the study groups (p > 0.05). Plasma levels of the adipokines were also independent of the gene profiles (p > 0.05). Adipokine plasma levels did not change in patients with H + CP/T2DM + CP compared to HC, but we did identify a specific polymorphism in the ADIPOQ gene that was associated with CP. Although the ADIPOQ + 45G/T (rs2241766) gene variant may be a candidate biomarker for CP, further research is required in larger populations with different ethnic backgrounds before any final conclusions can be drawn about the role of this gene in CP.
Links
GB14-37368G, research and development project |
| ||
MUNI/A/1008/2017, interní kód MU |
| ||
MUNI/A/1546/2018, interní kód MU |
| ||
ROZV/25/LF/2017, interní kód MU |
|